Prevention of Stretch Marks in Expectant Mothers (NCT07467837) | Clinical Trial Compass
RecruitingNot Applicable
Prevention of Stretch Marks in Expectant Mothers
Australia10,000 participantsStarted 2026-02-24
Plain-language summary
PRIME Mothers is a national observational trial designed to evaluate patient outcomes with Stratamark® for the prevention of stretch marks during pregnancy and the postpartum period. The study is designed to fit seamlessly into routine clinical practice, with digital follow-up and home resupply, minimising clinic involvement.
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Pregnant women at any gestational age.
* Participants who are in good health, including those that are carrying multiples, who are 18 years of age or older.
* Confirmed absence of pre-existing stretch marks on the abdomen.
* Agree to apply Stratamark according to the prescribed protocol for the duration of the study.
* Ability to complete remote online surveys via an electronic device.
* Provide signed informed consent to participate in the study.
Exclusion Criteria:
* Visible stretch marks on the abdomen prior to enrollment.
* Pre-existing skin conditions (e.g., eczema, psoriasis), on the abdomen that could interfere with product application or assessment of stretch marks.
* Known hypersensitivity or allergy to any of the ingredients in Stratamark.
* Use of other topical treatments on the abdomen, including but not limited to oils, or creams targeting stretch mark prevention.
* Participants unable to give informed consent, or unable to have written consent provided on their behalf.
* Participants who cannot administer the treatment or have the treatments administered as per the directions for use.
What they're measuring
1
Incidence of stretch marks
Timeframe: From enrolment until 6-8 weeks postpartum